LINC00691: A Long Intergenic Non-Protein Coding RNA (G152024)

Target Name: LINC00691

NCBI ID: G152024

LINC00691

Other Name(s): Long intergenic non-protein coding RNA 691 | long intergenic non-protein coding RNA 691

LINC00691: A Long Intergenic Non-Protein Coding RNA

LINC00691 is a long non-protein-coding RNA (lncRNA) molecule that has been identified in various organisms, including humans. It has a unique feature in that it is not only a non-protein molecule but also a functional RNA molecule with various functions in gene regulation, metabolism, and signaling pathways. LINC00691 is of great interest to researchers because of its potential as a drug target or biomarker. This article will discuss the biology, function, and potential applications of LINC00691.

Biology

LINC00691 is a transcribed RNA molecule that is derived from genomic DNA. It is characterized by its ability to interact with various cellular components, including chromatin, RNA factors, and protein partners. LINC00691 is a good candidate for a drug target because of its unique structure and the signaling pathways it involves.

Function

LINC00691 plays a variety of functions in gene regulation and metabolism. One of its well-established functions is its role in cell signaling pathways. LINC00691 has been shown to be involved in the regulation of cell adhesion, migration, and invasion. It has also been shown to play a role in the regulation of cell proliferation and apoptosis.

Another function of LINC00691 is its role in metabolism. LINC00691 has been shown to be involved in the regulation of glucose metabolism and lipid metabolism. It has been shown to interact with various enzymes involved in these processes and to regulate their activity.

Potential Applications

The potential applications of LINC00691 as a drug target or biomarker are vast. If approved, LINC00691 could be used to treat various diseases, including cancer, diabetes, and cardiovascular disease.

In cancer, LINC00691 has been shown to be involved in the regulation of cell adhesion and migration, which could make it an effective target for anti-cancer drugs. Additionally, LINC00691 has been shown to play a role in the regulation of cell proliferation, which could make it an effective target for anti-mitochondrial drugs.

In diabetes, LINC00691 has been shown to be involved in the regulation of glucose metabolism, which could make it an effective target for diabetes treatments.

In cardiovascular disease, LINC00691 has been shown to be involved in the regulation of cell proliferation and apoptosis, which could make it an effective target for cardiovascular disease treatments.

Conclusion

In conclusion, LINC00691 is a long non-protein-coding RNA molecule with various functions in gene regulation and metabolism. Its unique structure and the signaling pathways it involves make it an attractive candidate as a drug target or biomarker. Further research is needed to fully understand the functions of LINC00691 and its potential applications in disease treatment.

Protein Name: Long Intergenic Non-protein Coding RNA 691

The "LINC00691 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00691 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets